<DOC>
	<DOCNO>NCT00735709</DOCNO>
	<brief_summary>The purpose study determine effectiveness safety vortioxetine , daily ( QD ) , patient Major Depressive Disorder .</brief_summary>
	<brief_title>Efficacy Study Vortioxetine ( Lu AA21004 ) Adults With Major Depressive Disorder</brief_title>
	<detailed_description>The drug test study call vortioxetine . Vortioxetine test treat depression adult major depressive disorder ( MDD ) . This study look MDD relief people take vary dosage vortioxetine . The study enrol 560 patient . Participants randomly assign ( chance , like flip coin ) one four treatment groups—which remain undisclosed patient study doctor study ( unless urgent medical need ) : - Vortioxetine 1 mg - Vortioxetine 5 mg - Vortioxetine 10 mg - Placebo ( dummy inactive pill ) - capsule look like study drug active ingredient . All participant ask take one capsule time day throughout study . This multi-centre trial conduct Europe , Asia , Australia , South Africa . The overall time participate study 14 week . Participants make 7 visit clinic , contact telephone 4 week last dose study drug follow-up assessment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Vortioxetine</mesh_term>
	<criteria>Has primary diagnosis major depressive episode accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) criterion . The report duration current major depressive episode least 3 month . Has Montgomery Åsberg Depression Rating Scale ( MADRS ) total score ≥26 . A male female childbearing potential sexually active agrees use adequate contraception Screening throughout duration study 1 month last dose study medication . Has 1 follow : Any current psychiatric disorder major depressive disorder define DSMIVTR . Current past history : manic hypomanic episode , schizophrenia psychotic disorder , include major depression psychotic feature , mental retardation , organic mental disorder , mental disorder due general medical condition define DSMIVTR . Any substance disorder ( except nicotine caffeine ) within previous 6 month define DSMIVTR . ( must negative urine drug screen prior Baseline ) . Presence history clinically significant neurological disorder ( include epilepsy ) . Neurodegenerative disorder ( Alzheimer disease , Parkinson disease , multiple sclerosis , Huntington disease , etc ) . Has significant risk suicide accord investigator 's opinion score ≥5 item 10 ( suicidal thought ) Montgomery Åsberg Depression Rating Scale , make suicide attempt previous 6 month . Currently receive formal cognitive behavioral therapy , systematic psychotherapy , plan initiate therapy study . Has clinically significant unstable illness . Has previously fail respond adequate treatment selective serotonin reuptake inhibitor and/or serotoninnorepinephrine reuptake inhibitor . Has receive electroconvulsive therapy within 6 month prior Screening . Has alanine aminotransferase , aspartate aminotransferase , total bilirubin level &gt; 1.5 time upper limit normal . Has serum creatinine &gt; 1.5 × upper limit normal . Has previous history cancer remission le 5 year . Has thyroid stimulate hormone value outside normal range . Has abnormal electrocardiogram .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Depression</keyword>
	<keyword>Depressive Disorder</keyword>
	<keyword>Mood Disorder</keyword>
	<keyword>Mental Disorder</keyword>
	<keyword>Melancholia , Involutional</keyword>
	<keyword>Paraphrenia , Involutional</keyword>
	<keyword>Drug Therapy</keyword>
</DOC>